Alan E. Fletcher

694 total citations
12 papers, 430 citations indexed

About

Alan E. Fletcher is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Alan E. Fletcher has authored 12 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in Alan E. Fletcher's work include Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Alan E. Fletcher is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Alan E. Fletcher collaborates with scholars based in United States and United Kingdom. Alan E. Fletcher's co-authors include George Marshall, Alison J. Smith, Smita S. Patel, Kerry L. Chapman, John Atack, Julie Kerby, Jonathan D. Silk, Charles Adkins, Keith A. Wafford and Ruth M. McKernan and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Alan E. Fletcher

12 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan E. Fletcher United States 9 229 223 130 50 37 12 430
Ko Hasebe Japan 16 264 1.2× 243 1.1× 100 0.8× 22 0.4× 25 0.7× 25 477
Elizabeth A. Harley United States 14 260 1.1× 429 1.9× 92 0.7× 26 0.5× 73 2.0× 19 644
Makoto Oka Japan 12 196 0.9× 152 0.7× 87 0.7× 26 0.5× 14 0.4× 24 388
Kethireddy V.V. Ananthalakshmi Kuwait 13 122 0.5× 147 0.7× 183 1.4× 18 0.4× 27 0.7× 21 463
Alan D. Neubert United States 6 136 0.6× 145 0.7× 120 0.9× 41 0.8× 18 0.5× 7 370
Richard W. Zink United States 11 149 0.7× 243 1.1× 78 0.6× 18 0.4× 48 1.3× 19 523
Junki Katsube Japan 10 178 0.8× 125 0.6× 117 0.9× 23 0.5× 17 0.5× 50 413
M Quarum United States 6 404 1.8× 484 2.2× 41 0.3× 24 0.5× 37 1.0× 8 627
Vilma Ruperto United States 11 498 2.2× 500 2.2× 215 1.7× 33 0.7× 13 0.4× 19 863
Louise Webdale United Kingdom 8 181 0.8× 172 0.8× 96 0.7× 13 0.3× 25 0.7× 10 378

Countries citing papers authored by Alan E. Fletcher

Since Specialization
Citations

This map shows the geographic impact of Alan E. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan E. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan E. Fletcher more than expected).

Fields of papers citing papers by Alan E. Fletcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan E. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan E. Fletcher. The network helps show where Alan E. Fletcher may publish in the future.

Co-authorship network of co-authors of Alan E. Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of Alan E. Fletcher. A scholar is included among the top collaborators of Alan E. Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan E. Fletcher. Alan E. Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Smith, Alison J., Jonathan D. Silk, Charles Adkins, et al.. (2001). Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric AcidAReceptors Determined Using36Cl Ion Flux. Molecular Pharmacology. 59(5). 1108–1118. 111 indexed citations
2.
Smith, Alison J., Jonathan D. Silk, Charles Adkins, et al.. (2001). Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric AcidA Receptors Determined Using 36Cl Ion Flux. Molecular Pharmacology. 59(5). 1108–1118. 1 indexed citations
3.
Carling, Robert W., Kevin W. Moore, Christopher R. Moyes, et al.. (1999). 1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one:  A Selective High-Affinity Antagonist for the Human Dopamine D4Receptor with Excellent Selectivity over Ion Channels. Journal of Medicinal Chemistry. 42(14). 2706–2715. 50 indexed citations
4.
Collins, Ian, Joseph G. Neduvelil, Michael Rowley, et al.. (1998). Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor. Bioorganic & Medicinal Chemistry. 6(10). 1731–1743. 10 indexed citations
5.
Collins, Ian, Michael Rowley, Frances Emms, et al.. (1998). 3-(1-Piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channels. Bioorganic & Medicinal Chemistry. 6(6). 743–753. 20 indexed citations
6.
Castro, José L., Richard G. Ball, Howard B. Broughton, et al.. (1996). Controlled Modification of Acidity in Cholecystokinin B Receptor Antagonists:  N-(1,4-Benzodiazepin-3-yl)-N ‘-[3-(tetrazol-5-ylamino)phenyl]ureas. Journal of Medicinal Chemistry. 39(4). 842–849. 59 indexed citations
7.
Showell, Graham A., Stephen R. Fletcher, Joseph G. Neduvelil, et al.. (1995). C5-piperazinyl-1,4-benzodiazepines, water-soluble, orally bioa vailable CCKB/gastrin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 5(24). 3023–3026. 8 indexed citations
8.
Showell, Graham A., Joseph G. Neduvelil, Stephen R. Fletcher, et al.. (1994). High-Affinity and Potent, Water-Soluble 5-Amino-1,4-benzodiazepine CCKB/Gastrin Receptor Antagonists Containing a Cationic Solubilizing Group. Journal of Medicinal Chemistry. 37(6). 719–721. 47 indexed citations
9.
Freedman, Stephen B., Smita S. Patel, Alesha Smith, et al.. (1994). A Second Generation of Non‐Peptide Cholecystokinin Receptor Antagonists and Their Possible Therapeutic Potential. Annals of the New York Academy of Sciences. 713(1). 312–318. 8 indexed citations
10.
Bock, Mark G., Robert M. DiPardo, Daniel F. Veber, et al.. (1994). Second-Generation Benzodiazepine CCK-B Antagonists. Development of Subnanomolar Analogs with Selectivity and Water Solubility. Journal of Medicinal Chemistry. 37(6). 722–724. 33 indexed citations
11.
Patel, Sima, Alesha Smith, Kerry L. Chapman, et al.. (1994). Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.. Molecular Pharmacology. 46(5). 943–948. 35 indexed citations
12.
McKnight, A.T., Janet J. Maguire, Alan E. Fletcher, et al.. (1991). Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors. British Journal of Pharmacology. 104(2). 355–360. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026